Quantum Brain Sensors Could Help Identify Dementia and Other Brain Diseases

1 December, 2021

Identifying brain diseases such as dementia, ALS, and Parkinson’s may be easier in the future thanks to highly sensitive quantum brain sensors

New Wristwatch Identifies Seizure Patterns in People With Epilepsy

1 December, 2021

Study: Sleep Disorders Linked with More Severe COVID-19 Outcomes

1 December, 2021

Featured Videos

ALS - Overview

ALS - Treatment

ALS - Stress

ALS - Dietary Strategy

ALS - Exercise Strategy

Vascular Dementia - Overview

Vascular Dementia - Right Amount of Sleep

Vascular Dementia - Tips and Suggestions

Epilepsy - Facts

Epilepsy - Benefits of Sleep

Epilepsy - Benefits of Exercise

Epilepsy - Consequences of Stress

Epilepsy - Precautions

Epilepsy - The Correct Food

Epilepsy - Treatment

ALS

FDA Gives Orphan Drug Designation to Ketamine for ALS

10 September, 2021

The FDA has recently given orphan drug designation to Ketamine for treatment of Amyotrophic Lateral Sclerosis (ALS)

Trial Shows Arthritis Treatment Safe for ALS and Eases Inflammation

10 September, 2021

Tocilizumab, an established rheumatoid arthritis (RA) treatment, was found to reduce inflammation in ALS patients in a new study.

Cholesterol Metabolism Defects Linked to ALS

10 September, 2021

A new study published in the Journal of Cell Biology has linked a defect in cholesterol metabolism to the development of neurological damage caused by amyotrophic lateral sclerosis (ALS).

Migraine

Migraine

Study: How Effective Is Erenumab in Preventing Migraine?

A new study shows that erenumab is helpful in treating headaches and migraine in patients by blocking a certain protein in the body.

Migraine

Atogepant Shows Promise In Preventing Migraines

Atogepant, a prospective drug currently being developed by AbbVie, lowered migraine days in a recent study and showed optimistic results.

Migraine

COVID-19 & New-Onset Migraine and Tension-Type Headaches

A new study published in The Journal of Headache and Pain has aimed to examine the relationship between headaches and COVID-19.

Multiple Sclerosis

New Study Shows Promise In J&J’s Ponvory For MS

18 November, 2021

Johnson and Johnson’s new drug to treat multiple sclerosis, Ponvory, has performed well in a recent study compared to a similar MS drug. 

MS Stem Cell Trial Receives FDA Authorization

10 September, 2021

The FDA recently approved a Phase II clinical trial which aims to treat MS patients using autologous adipose-derived mesenchymal stem cell infusions

Cognitive Rehabilitation Programs Effective In Treating MS-Related Cognitive Dysfunction

18 November, 2021

A new study has found that undergoing cognitive rehabilitation is effective at restoring cognition in individuals with MS.

Study: Newly Diagnosed MS Shows Cluster of Symptoms

10 September, 2021

A new study published in the Multiple Sclerosis Journal has found that several common symptoms of MS often cluster together for patients in their first year following diagnosis

Seizure Disorder

Seizure Disorder

Benefits From Long-Term Video EEG Monitoring in Epilepsy Patients

A new study has determined that long-term video EEG monitoring is an effective diagnostic tool for epilepsy in children.

Seizure Disorder

Cerebral Cavernous Malformations Increase Seizure Risk

A recent study found that having an inherited cerebral cavernous malformation increases an individual’s risk of seizures.

Seizure Disorder

New Wristwatch Identifies Seizure Patterns in People With Epilepsy

A new wristwatch aims to warn people with epilepsy before a seizure, so they can take steps to prevent it or minimize its effects.

Sleep Disorder

Study: Sleep Disorders Linked with More Severe COVID-19 Outcomes

1 December, 2021

A study conducted at the Cleveland Clinic suggests some sleep disorders may be linked to more severe outcomes from COVID-19

Xywav: A FDA-Approved Treatment for Chronic Sleep Disorder

10 September, 2021

The FDA has approved Xywav - a new treatment for idiopathic hypersomnia (an uncommon disorder that causes constant daytime sleepiness).

Review: Type 2 Diabetes Increases Risk & Complications of Sleep Disorders

10 September, 2021

A recent review has underlined the prevalence of sleep disorders among patients with type 2 diabetes and its impact on health outcomes.

Send this to a friend